Microencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 Favorably Modulates Gut Microbiota and Reduces Circulating Endotoxins in F344 Rats
Figure 1
Effect of alginate-poly-L-lysine-alginate (APA) microencapsulated B. infantis ATCC 15697 supplementation on the abundance of fecal bacteria at endpoint (day 38): (a) bacteria that do not produce endotoxins and (b) potential endotoxins-producing bacteria. F344 rats were gavaged daily with APA microencapsulated B. infantis ATCC 15697 or saline during 38 days. Data represent the means ± SEM () of the abundance of each bacterial group (mean percentage of total bacteria) at endpoint (day 38). Statistical analysis was performed using unpaired Student’s t-test or the Mann-Whitney test. Indicates statistical significance between treatment groups ().
